FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Nonopioid Alternatives Pamphlet
July 1, 2020

2020 legislation amended the requirements for non-opioid alternatives. Click here to access the pamphlet for “Information on Nonopioid Alternatives for the Treatment of Pain” Continue reading


New Legislation Impacting Your Profession
June 29, 2020

Click here to view a full list of bill summaries from the 2020 Florida Legislative Session that may impact your profession. Continue reading